Core Viewpoint - Shares of ViaSat (VSAT) have increased by 8.7% over the past four weeks, closing at $9.78, with a mean price target of $18.86 indicating a potential upside of 92.8% [1] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $16.66, where the lowest estimate is $10 (2.3% increase) and the highest is $56 (472.6% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [7] Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.8%, with one estimate moving higher and no negative revisions [10] Zacks Rank and Investment Potential - ViaSat holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential upside [11] - While consensus price targets may not reliably indicate the extent of gains, they can provide a directional guide for price movement [12]

Group 1 - Gray Media (GTN) closed at $5.12, with a 24.9% gain over the past four weeks, and a mean price target of $6.75 indicating a 31.8% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $1.89, where the lowest estimate is $4 (21.9% decline) and the highest is $8 (56.3% increase) [2] - Analysts show strong agreement on GTN's ability to report better earnings, with a positive trend in earnings estimate revisions suggesting potential upside [4][9] Group 2 - The Zacks Consensus Estimate for GTN has increased by 3.6% due to one upward revision in the last 30 days, with no negative revisions [10] - GTN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [12]

Core Viewpoint - ANI Pharmaceuticals (ANIP) shows potential for significant upside, with a mean price target of $80.83 indicating a 32.4% increase from the current price of $61.05 [1] Price Targets - The average price target consists of six estimates ranging from a low of $62 to a high of $94, with a standard deviation of $10.52, suggesting variability in analyst opinions [2] - The lowest estimate indicates a modest increase of 1.6%, while the highest suggests a potential upside of 54% [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement direction [7] Analyst Sentiment - Analysts have recently shown increased optimism about ANIP's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [9] - Over the last 30 days, three estimates have been revised upward, leading to a 22.5% increase in the Zacks Consensus Estimate [10] Zacks Rank - ANIP holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11] Conclusion on Price Targets - While consensus price targets may not be reliable for predicting exact price movements, they can provide a useful guide for understanding potential price direction [12]

Group 1 - National Vision (EYE) closed at $11.72, with a 0.3% gain over the past four weeks, and a mean price target of $15.11 indicating a 28.9% upside potential [1] - The average price targets range from $13 to $20, with a standard deviation of $2.76, suggesting a variability in estimates; the lowest estimate indicates a 10.9% increase, while the highest points to a 70.7% upside [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][9] Group 2 - The Zacks Consensus Estimate for EYE has increased by 18.8% due to two upward revisions in earnings estimates over the last 30 days [10] - EYE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [12]